The University Hospitals Bristol and Weston NHS Foundation Trust is a National Health Service foundation trust in Bristol and Weston-super-Mare, England.

During the past decade, University Hospitals Bristol NHS Foundation Trust conducted 74 clinical trials. In the 10-year time frame, 74 clinical trials started and 21 clinical trials were completed, i.e. on average, 28.4% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 17 clinical trials were completed. i.e. 60.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospitals Bristol NHS Foundation Trust" #1 sponsor was "Pfizer" with 11 trials, followed by "Nutricia UK Ltd" with 6 trials sponsored, "University Hospitals Bristol and Weston NHS Foundation Trust" with 5 trials sponsored, "University of Birmingham" with 4 trials sponsored and "Vertex Pharmaceuticals Incorporated" with 4 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 57 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospitals Bristol NHS Foundation Trust" #1 collaborator was "University College, London" with 7 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 4 trials as a collaborator, "Astellas Pharma Inc" with 3 trials as a collaborator, "Cancer Research UK" with 3 trials as a collaborator and "Great Ormond Street Hospital for Children NHS Foundation Trust" with 3 trials as a collaborator. Other collaborators include 143 different institutions and companies that were collaborators in the rest 128 trials.

According to Clinical.Site data, the most researched conditions in "University Hospitals Bristol NHS Foundation Trust" are "Cystic Fibrosis" (5 trials), "Ovarian Cancer" (3 trials), "Prostate Cancer" (3 trials), "Prostatic Neoplasms" (3 trials) and "Acute Myeloid Leukaemia" (2 trials). Many other conditions were trialed in "University Hospitals Bristol NHS Foundation Trust" in a lesser frequency.

Most popular intervention types in "University Hospitals Bristol NHS Foundation Trust" are "Drug" (54 trials), "Other" (14 trials), "Biological" (8 trials), "Procedure" (8 trials) and "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Enzalutamide" (5 trials), "ELX/TEZ/IVA" (4 trials), "IVA" (4 trials) and "Avelumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "University Hospitals Bristol NHS Foundation Trust" are 81 trials for "All" genders, 8 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "University Hospitals Bristol NHS Foundation Trust". undefined are not yet recruiting, 18 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in University Hospitals Bristol NHS Foundation Trust, 2 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospitals Bristol NHS Foundation Trust, 7 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 19 trials that are defined as “Not Applicable".

University Hospitals Bristol NHS Foundation Trust has several departments that took part in Clinical trials: "Bristol Heart Institute" - 17 trials, "Bristol Haematology and Oncology Centre" - 162 trials, "Bristol Royal Hospital for Children" - 91 trials, "Bristol Eye Hospital;Retinal Treatment and Research Unit" - 4 trials, "Bristol Univ Hosp Congenital Heart Centre" - 2 trials, "Department of Gastroenterology, Old Building" - 2 trials, "Bristol Dental Hospital and School" - 2 trials